N/A
N=34
Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
Atrial Fibrillation
Bottom Line
View on ClinicalTrials.gov: NCT03744936 ↗Enrolled (actual)
34
Serious AEs
—
Results posted
Jan 2025
Primary outcome: Primary: Interview Process — 34 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Feedback (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Feb 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Interview Process |
34 | — |
Summary
The researchers are observing subject and clinician interaction in order to develop future education materials that will help patients and clinicians discuss atrial fibrillation and options to treat it.
Eligibility Criteria
- Must be 18 or older
- Must have an appointment for Atrial Fibrillation
- Must not have dementia
- Must not have severe hearing or vision impairment Patients will be given a written consent Guests that accompany patients will be given an oral consent KER unit PAG members will be given an oral consent
Data sourced from ClinicalTrials.gov (NCT03744936). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.